Tmem204 regulates cellular and physiological processes through its interaction with key pathways:
Angiogenesis & Vascular Development: Modulates vascular endothelial growth factor (VEGF) signaling via interactions with KDR and FLT4 receptors .
Cell Adhesion: Co-localizes with β-catenin at adherens junctions, reducing intercellular adhesion upon overexpression .
Cancer Prognosis: Upregulated in liver hepatocellular carcinoma (LIHC) and correlates with immune infiltration (e.g., CD8+ T cells, macrophages) .
Hypoxia Response: Induced under low oxygen conditions, influencing endothelial cell behavior .
| Protein/Molecule | Role in Pathway | Interaction Score |
|---|---|---|
| KDR (VEGFR2) | VEGF signaling, endothelial proliferation | 0.788 |
| TJP1 (ZO-1) | Tight junction regulation | 0.596 |
| CLEC14A | Angiogenesis regulation | 0.541 |
Recombinant Mouse Tmem204 is utilized in:
Cancer Studies: Investigating LIHC prognosis and immune microenvironment modulation .
Vascular Biology: Modeling angiogenesis and vascular permeability .
Toxicology: Assessing chemical-induced gene expression changes (e.g., cadmium, lead acetate) .
| Product ID | Species | Tag | Expression System |
|---|---|---|---|
| TMEM204-16986M | Mouse | His | Mammalian Cells |
| RFL4395RF | Rat | His | E. coli |
| TMEM204-9349M | Mouse | His-Fc-Avi | HEK293 |
Custom production options (5–9 weeks lead time) include species-specific modifications (e.g., zebrafish, bovine) .
Activity: Functional assays confirm adherence to VEGF signaling and hypoxia-response pathways .
Cross-Reactivity: 97% sequence identity with human and rat orthologs enables cross-species studies .
Limitations: Limited data on post-translational modifications in recombinant forms.
Opportunities: Explore therapeutic targeting in cancer and vascular diseases via CRISPR or antibody-based tools .
This synthesis integrates molecular, functional, and practical insights, positioning Recombinant Mouse Tmem204 as a vital tool for vascular biology and oncology research.
TMEM204 is a member of the TMEM family that plays a critical role in cell adhesion and cellular permeability at adherens junctions. Research indicates it regulates cell function and angiogenesis . Also known by synonyms including C16orf30, FLJ20898, claudin-like protein 24 (CLP24), and MGC111564, this protein has significant implications in cellular communication and tissue integrity . TMEM204's function appears to be conserved across species, though species-specific variations may exist in regulatory mechanisms.
TMEM204 expression varies significantly between normal and disease tissues. In cancer research, TMEM204 has been found to be up-regulated in multiple cancer types . Specifically in liver hepatocellular carcinoma (LIHC), TMEM204 expression is significantly higher than in normal tissues across all histologic subtypes including hepatocellular carcinoma, fibrolamellar carcinoma, and hepatocholangiocarcinoma . This differential expression pattern suggests TMEM204 may serve as a potential diagnostic biomarker, particularly for LIHC.
Recombinant mouse TMEM204 serves as a valuable tool in cancer research, particularly for studying its role in liver hepatocellular carcinoma. Research has demonstrated that high TMEM204 expression correlates with good prognosis in LIHC patients . This protein can be used in functional studies to investigate mechanisms behind this correlation. Additionally, recombinant TMEM204 enables researchers to examine its interactions with immune cells, as TMEM204 expression has been significantly correlated with infiltration of CD8+ T cells (Rho=0.202, P=1.58e-04), CD4+ T cells (Rho=0.256, P=1.39e-06), macrophages (Rho=0.203, P=1.48e-04), neutrophils (Rho=0.157, P=3.56e-03), and myeloid dendritic cells (Rho=0.193, P=3.04e-04) in the tumor microenvironment .
To investigate TMEM204's function in cell adhesion, researchers can employ the following methodological approaches:
Loss-of-function studies using siRNA knockdown or CRISPR-Cas9 to reduce or eliminate TMEM204 expression
Gain-of-function studies using purified recombinant mouse TMEM204 or overexpression systems
Cell adhesion assays to measure changes in adhesive properties following TMEM204 manipulation
Trans-epithelial/endothelial electrical resistance (TEER) measurements to assess changes in cellular permeability
Immunofluorescence microscopy to visualize TMEM204 localization at adherens junctions
Co-immunoprecipitation to identify binding partners at cell-cell junctions
These approaches allow researchers to elucidate TMEM204's specific contributions to adherens junction formation and function, building upon the established role of TMEM204 in cell adhesion and permeability .
Several expression systems are available for producing recombinant mouse TMEM204, each with distinct advantages:
| Expression System | Advantages | Applications |
|---|---|---|
| Mammalian Cells (HEK293) | Proper folding, post-translational modifications | Functional studies, binding assays |
| E. coli | High yield, cost-effective | Structural studies, antibody production |
| Mus musculus cells | Native environment for mouse protein | Species-specific interaction studies |
Various tags can be incorporated for purification and detection purposes, including His, Avi, and Fc tags . The choice of expression system should be guided by the intended research application and the requirement for post-translational modifications that may be critical for TMEM204 function.
Quality control for recombinant mouse TMEM204 should include:
Purity assessment through SDS-PAGE and/or HPLC
Identity confirmation via mass spectrometry and Western blotting
Activity verification through functional assays specific to TMEM204's role in adherens junctions
Endotoxin testing if the protein will be used in cell culture or in vivo experiments
Coefficient of variation (CV) calculation for replicated quality control samples to assess reproducibility, with CV < 30% considered acceptable for most applications
Methylation analysis of TMEM204 can provide insights into its epigenetic regulation, particularly in cancer research where TMEM204 methylation levels in LIHC were found to be higher than in normal tissues . The methodological approach includes:
Bisulfite conversion of DNA, which converts unmethylated cytosines to uracil while leaving methylated cytosines unchanged
Analysis using methylation-specific PCR or bisulfite sequencing
Quantification using the Beta value, which represents the ratio of methylated probe intensity to the sum of methylated and unmethylated probe intensity
Interpretation using established thresholds: Beta values of 0.7-0.5 indicate hypermethylation, while values of 0.3-0.25 indicate hypomethylation
Correlation of methylation patterns with TMEM204 expression and clinical outcomes
This analytical approach can reveal how epigenetic modifications influence TMEM204 expression in different tissue contexts and disease states.
Co-expression analysis represents a powerful approach to understanding TMEM204's functional networks and regulatory mechanisms. Implementation steps include:
Generate gene expression data across multiple conditions or cell types
Apply co-expression analysis methods to identify genes with expression patterns similar to TMEM204
Construct gene modules containing TMEM204 and its co-expressed genes using methods like WGCNA (Weighted Gene Co-expression Network Analysis)
Perform functional enrichment analysis on these modules to identify biological pathways associated with TMEM204
Validate predicted functional associations through experimental approaches
This approach has successfully identified pathways associated with TMEM204, including the p53 signaling pathway and Fanconi anemia pathway . Co-expression analysis combined with functional enrichment has proven valuable for improving the identification and prioritization of trans-eQTLs (genetic variants that affect gene expression at a distance) .
Integrating proteomics and transcriptomics data provides a comprehensive view of TMEM204 regulation and function. The OmicsEV R package offers a systematic approach for this integration :
Data depth assessment: Evaluate the number of identified and quantifiable features in each dataset
Data normalization: Visualize feature abundance distribution using boxplots and density plots
Batch effect evaluation: Apply silhouette width and principal component regression analysis
Biological signal assessment: Use protein complex correlation analysis, gene function prediction, and machine learning models
Multi-omics concordance analysis: Calculate mRNA-protein correlation metrics for both gene-wise and sample-wise correlations
This integrated approach can reveal post-transcriptional regulation of TMEM204 and identify discrepancies between transcript and protein levels that may have functional significance.
Several computational tools are particularly valuable for TMEM204 research:
OmicsEV: For comprehensive quality evaluation of RNA-seq and proteomics data tables, enabling researchers to assess data quality and optimize data processing methods
TIMER2.0 (Tumor Immune Estimation Resource): For analyzing correlations between TMEM204 expression and immune cell infiltration in different tumor types
STRING: For building Protein-Protein Interaction Networks to identify potential interaction partners of TMEM204
Webgestalt: For functional analysis of TMEM204 and its related genes
GEPIA2, UALCAN, and Oncolnc: For evaluating the prognostic potential of TMEM204 across different cancer types
These tools collectively provide a robust computational framework for exploring TMEM204 biology from multiple perspectives.
Researchers may encounter contradictory results regarding TMEM204 expression across different studies. These discrepancies can be addressed through:
Careful evaluation of study methodologies, including:
RNA extraction and quality assessment procedures
Expression quantification methods (qPCR, RNA-seq, microarray)
Normalization approaches and reference genes used
Implementation of batch effect correction using tools like OmicsEV, which provides methods for batch effect evaluation including PCA plots and silhouette width calculation
Consideration of tissue-specific effects, as TMEM204 expression patterns and prognostic significance vary across different cancer types
Assessment of tumor heterogeneity and microenvironmental factors that may influence TMEM204 expression
Replication studies with larger sample sizes and standardized protocols
Understanding the methodological differences between studies is essential for reconciling seemingly contradictory findings about TMEM204 expression and function.
Validation of functional studies with recombinant mouse TMEM204 should include:
Multiple complementary assays to measure the same biological phenomenon
Appropriate controls including:
Vehicle-only controls
Heat-inactivated recombinant protein
Isotype controls for antibody-based detection
Dose-response experiments to establish concentration-dependent effects
Genetic validation through:
siRNA knockdown of endogenous TMEM204
Rescue experiments using recombinant protein in knockout systems
Cross-validation with human TMEM204 to assess species-specific differences
Reproducibility assessment using the coefficient of variation (CV), with CV < 30% considered acceptable for most biological assays
Following these validation practices ensures robust and reproducible results when studying recombinant mouse TMEM204 function.
TMEM204's role in immune regulation represents an emerging research direction based on its correlation with immune cell infiltration in tumors. In LIHC, TMEM204 expression significantly correlates with infiltration of CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and myeloid dendritic cells . These correlations suggest several potential functions:
Regulation of immune cell recruitment or retention in tissue microenvironments
Modulation of immune checkpoint pathways
Influence on antigen presentation processes
Contribution to cytokine signaling networks
Role in maintaining tissue-specific immune homeostasis
Investigating these potential functions using recombinant mouse TMEM204 in immune cell co-culture systems could provide valuable insights into TMEM204's role in immunobiology.
While the search results provide limited direct information on TMEM204's role in development, its functions in angiogenesis and cell adhesion suggest important developmental contributions. Future research directions could include:
Temporal expression analysis during embryonic development
Tissue-specific knockout studies to assess developmental phenotypes
Lineage tracing experiments to identify TMEM204-expressing progenitor populations
Investigation of TMEM204's role in tissue morphogenesis and organogenesis
Analysis of potential genetic variants affecting TMEM204 expression during development using techniques similar to those described for identifying trans-eQTLs
These approaches would help elucidate TMEM204's contributions to normal development and potentially reveal insights into developmental disorders.